Table 3.

Patient Survival and Recurrence End Point Analyses.

Patient ID	Days Surviving	Days to Recurrence	CF95 max of Tissue Sections Examined, %	EF5 Value Near Ki-67+ Cells* (CF95), %	Ratio,† %	PI,‡ %
50	677	235	7.9	1.0	12.4	2.8
115§	1106	1106	5.0	1.5	30.5	2.8
39	1054	938	26.1	10.5	40.5	3.1
38	691	488	6.9	3.2	46.6	15.5
33	227	126	14.0	8.6	61.2	5.3
74	241	137	5.7	3.7	64.1	6.2
42	641	121	19.6	13.3	67.7	6.8
55	831	187	15.1	11.4	75.3	6.0
127	371	100	7.8	5.9	75.9	6.0
57	470	182	17.5	14.1	80.4	2.5
101	190	112	4.2	3.4	81.8	1.3
123	528	117	3.2	2.6	82.3	4.6
52	489	322	26.7	22.7	85.2	4.9
107	700	262	19.3	17.2	89.5	5.1
32	130	130	21.6	19.9	91.9	11.8
58	124	124	5.5	5.3	96.6	2.0

^†Ratio = EF5 value near Ki-67+ cells (CF₉₅) / overall EF5 value (CF_{95 max}).

^‡PI = number of Ki-67+ nuclei/total number of nuclei stained with Hoechst 33342.

^§This patient is still alive without recurrence.